THE DEAL, AT A GLANCE
From the announcementHeaviside Industries
01Who is involvedBacked by Khosla Ventures, bringing, Stealth with $28M Series AFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedHeaviside Industries raised $60M Series B, announced 2026-08-12From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersHeaviside Industries' Series B supports an in vivo CAR therapy strategy for autoimmune disease and oncology using an mRNA-LNP platform.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Heaviside Industries · Financing Record
Explore source-linked visual explanations for Heaviside Industries. Unsupported claims are withheld while source review continues.
Record 10120 · Recorded date: 2026-08-12
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →